Annals of Hematology

, Volume 88, Issue 4, pp 375–377

Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin’s lymphoma in Hokkaido

  • Yutaka Tsutsumi
  • Akio Shigematsu
  • Satoshi Hashino
  • Junji Tanaka
  • Kouji Chiba
  • Nobuo Masauzi
  • Hajime Kobayashi
  • Mitsutoshi Kurosawa
  • Hiroshi Iwasaki
  • Masanobu Morioka
  • Masahiro Asaka
  • Masahiro Imamura
Letter to the Editor

References

  1. 1.
    Igarashi T, Kobayashi Y, Ogura M, Kinoshita T, Ohtsu T, Sasaki Y et al (2002) Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study. Ann Oncol 13:928–943 doi:10.1093/annonc/mdf155 PubMedCrossRefGoogle Scholar
  2. 2.
    Bermudez A, Marco F, Conde E, Mazo E, Recio M, Zubizarreta A (2000) Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma. Haematologica 85:894–895PubMedGoogle Scholar
  3. 3.
    Sharma VR, Fleming DR, Slone S (2000) Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 96:1184–1186PubMedGoogle Scholar
  4. 4.
    Suzan F, Ammor M, Ribrag V (2001) Fatal reactivation of cytomegalovirus infection after use of rituximab for a post transplantation lymphoproliferative disorder. N Engl J Med 345:1000 doi:10.1056/NEJM200109273451315 PubMedCrossRefGoogle Scholar
  5. 5.
    Goldberg SL, Pecora AL, Alter RS, Kroll MS, Rowley SD, Waintraub SE et al (2002) Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 99:1486–1488 doi:10.1182/blood.V99.4.1486 PubMedCrossRefGoogle Scholar
  6. 6.
    Czuczman MS, Grillo-Lopez AJ, White CA, Saleh M, Gordon L, Lobuglio AF, Jonas C, Kippenstein D, Dallire B, Varns C (1999) Treatment of patients with low grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17:268–276PubMedGoogle Scholar
  7. 7.
    Westhoff TH, Jochimsen F, Schmittel A, Stoffler-Meilicke M, Schafer JH, Zidek W et al (2003) Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 102:1930 doi:10.1182/blood-2003-05-1403 PubMedCrossRefGoogle Scholar
  8. 8.
    Ng HJ, Lim LC (2001) Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report. Ann Hematol 80:549–552 doi:10.1007/s002770100346 PubMedCrossRefGoogle Scholar
  9. 9.
    Dervite I, Hober D, Morel P (2001) Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med 344:68–69 doi:10.1056/NEJM200101043440120 PubMedCrossRefGoogle Scholar
  10. 10.
    Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Hiroe K, Obara S et al (2004) Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin’s lymphoma. Ann Hematol 83:58–60 doi:10.1007/s00277-003-0748-4 PubMedCrossRefGoogle Scholar
  11. 11.
    Tsutsumi Y, Kanamori H, Mori A, Tanaka J, Asaka M, Imamura M et al (2005) Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf 4:599–608 doi:10.1517/14740338.4.3.599 PubMedCrossRefGoogle Scholar
  12. 12.
    Pereau G, Dris N, Estines O, Derancourt C, Levy S, Bernard P (2006) Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol 155:1053–1056 doi:10.1111/j.1365-2133.2006.07451.x CrossRefGoogle Scholar
  13. 13.
    Yang SH, Kuo SH (2008) Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma. Ann Hematol 87:325–327 doi:10.1007/s00277-007-0396-1 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Yutaka Tsutsumi
    • 1
  • Akio Shigematsu
    • 2
  • Satoshi Hashino
    • 3
  • Junji Tanaka
    • 2
  • Kouji Chiba
    • 4
  • Nobuo Masauzi
    • 1
  • Hajime Kobayashi
    • 5
  • Mitsutoshi Kurosawa
    • 6
  • Hiroshi Iwasaki
    • 7
  • Masanobu Morioka
    • 8
  • Masahiro Asaka
    • 3
  • Masahiro Imamura
    • 2
  1. 1.Department of Internal MedicineHakodate Municipal HospitalHakodateJapan
  2. 2.Department of Hematology and OncologyHokkaido University Graduate School of MedicineSapporoJapan
  3. 3.Department of GastroenterologyHokkaido University Graduate School of MedicineSapporoJapan
  4. 4.Department of Internal MedicineAsahikawa Municipal HospitalAsahikawaJapan
  5. 5.Department of Internal MedicineObihiro Kosei HospitalObihiroJapan
  6. 6.Department of HematologyNational Cancer CenterSapporoJapan
  7. 7.Department of Internal MedicineSapporo Kosei HospitalSapporoJapan
  8. 8.Department of Internal Medicine Aiiku HospitalSapporoJapan

Personalised recommendations